Allergy and Asthma Proceedings

Article	Citations
Hereditary angioedema: Epidemiology and burden of disease	59
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome	44
The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?	41
COVID-19 in children: Pathogenesis and current status	31
Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy	29
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	28
Triggers and short-term prophylaxis in patients with hereditary angioedema	28
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination	26
Definition and classification of hereditary angioedema	26
COVID-19 in a patient with severe asthma using mepolizumab	23
Patient perspectives on the treatment burden of injectable medication for hereditary angioedema	23
Treatment strategies for postviral olfactory dysfunction: A systematic review	22
Clinical presentation of hereditary angioedema	22
Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)	22
Hereditary angioedema: Special considerations in women	21
Hereditary angioedema: On-demand treatment of angioedema attacks	20
Hereditary angioedema: Differential diagnosis, diagnostic tests, and family screening	19
Hereditary angioedema and shared decision making	19
Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation	18
Hereditary angioedema: Special considerations in children	18
The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome	18
Effect of COVID-19 on hereditary angioedema activity and quality of life	18
Psychology and hereditary angioedema: A systematic review	18
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis	18
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?	18

Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019	17
Hereditary angioedema: Long-term prophylactic treatment	17
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines	16
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation	16
Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies	15
Proactive management of penicillin and other antibiotic allergies	15
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience	15
Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies	15
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance	15
Shifts in allergy practice in a COVID-19 world: Implications of pre‐COVID-19 national health care provider and patient surveys of treatments for nasal allergies	15
Long-term efficacy of injected allergen immunotherapy for treatment of grass pollen allergy in elderly patients with allergic rhinitis	15
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications	15
Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic	15
Assessing the cost and quality-of-life impact of on-demand‐only medications for adults with hereditary angioedema	15
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	14
Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis	14
Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs	14
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study	14
Treg‐inducing capacity of genomic DNA of Bifidobacterium longum subsp. infantis	14
Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria	14
Hereditary angioedema: Investigational therapies and future research	13
Hereditary angioedema: Comprehensive management plans and patient support	13
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol	13
Successful treatment of coronavirus disease 2019 in a patient with asthma	13
Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base	12
Association of serum 25-OH vitamin D3 with serum IgE and the Pediatric Asthma Severity Score in patients with pediatric asthma	12
Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction	12
Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema	12
Treatment options for chronic rhinosinusitis with nasal polyps	11
Visceral obesity is associated with clinical and inflammatory features of asthma: A prospective cohort study	11
Phenotypes and natural history of food protein‐induced enterocolitis syndrome in the east Mediterranean region	11
Tropomyosin: A panallergen that causes a worldwide allergic problem	11
Accelerated/rush allergen immunotherapy	11
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management	11
Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema	11
Caregivers’ role in managing hereditary angioedema and perceptions of treatment-related burden	11
Atopic dermatitis: Correlation of severity with allergic sensitization and eosinophilia	10
Safety of subcutaneous allergen immunotherapy	10
Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management	10
Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations	10
Shrimp and cockroach co-sensitization in Southern China: Association with moth sensitization	10
Novel diagnostic techniques and therapeutic strategies for IgE‐mediated food allergy	10
Efficacy and safety of sublingual allergen immunotherapy	10
Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease	9
Weighing the benefits and risks of oral immunotherapy in clinical practice	9
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis	9
Considerations for asthma management and viral transmission in the era of COVID-19	9
Delayed allergic skin reactions to vaccines	9
Allergy immunotherapy: Future directions for the 2020s	9
Adherence and usage patterns of inhaled corticosteroids‐long-acting beta-agonists by using inhaler-monitoring technology	8

Serum levels of specific immunoglobulin E toDermatophagoides pteronyssinusallergen components in patients with allergic rhinitis or/and asthma	8
Evaluation of drug patch tests in children	8
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	8
Allergy to oak pollen in North America	8
Epinephrine autoinjector prescription filling after pediatric emergency department discharge	8
Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study	8
Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis	8
Idiopathic anaphylaxis: Diagnosis and management	8
The long COVID syndrome: A conundrum for the allergist/immunologist	8
Association between asthma symptom scores and perceived stress and trait anxiety in adolescents with asthma	8
COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results	8
Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States	7
Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria	7
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs	7
Asthma in pregnancy	7
COVID-19 in Italian children and adolescents: The role of allergy and asthma	7
Prevalence and management of aspirin hypersensitivity in a cardiology practice	7
Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2‐agonist in real-world patients with asthma	7
Patient perspectives on penicillin allergy and testing	7
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose	7
Short-term prophylaxis for children and adolescents with hereditary angioedema	7
Nasal reactivity evaluation in children with allergic rhinitis receiving grass pollen sublingual immunotherapy	7
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children	6
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease	6
Cat allergy in children and the effect of the COVID-19 pandemic	6
Evaluation of the peripheral blood eosinophil count as a predictor for fractional exhaled nitric oxide or bronchodilator reversibility test outcome	6
Negative predictive value of provocation tests for nonsteroidal anti-inflammatory drugs in children	6
Longitudinal experience with treatment of acquired angioedema using tranexamic acid	6
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy	6
Guidelines for management of hereditary angioedema: What is new? What is missing?	6
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes	6
Clinical phenotypes of childhood food allergies based on immune mechanisms: A multicenter study	6
Long-term adherence strategies for allergen immunotherapy	6
Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia	6
Paucigranulocytic asthma: Do sputum macrophages matter?	6
Chronic rhinosinusitis with nasal polyps management in the age of biologics	6
A 2-year-old girl with periprocedural anaphylaxis	6
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	6
A 48-year-old female with perioperative anaphylaxis	6
Venom allergen immunotherapy	6
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	5
Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?	5
Primary immunodeficiency diseases treated with immunoglobulin and associated comorbidities	5
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	5
Clinical features of anaphylaxis in children	5
Incidence of depression and its influencing factors in 387 patients with asthma from Xinjiang, China	5
56-year-old male with HIV and sudden cardiac arrest	5
Studies of mitochondrial and nuclear DNA released from food allergen‐activated neutrophils. Implications for non‐IgE food allergy	5
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	5
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	5
Ideal body position for epinephrine autoinjector administration	5
Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic	5
Serum immunoglobulin E reactivity to cross-reacting panallergen components in north-eastern Poland patients pollen sensitized	5
The war on infectious diseases: COVID-19 vaccines and the public: Challenges and solutions	5
Pearls and pitfalls: Cold-induced urticaria	5
Diagnostic value and safety of penicillin skin tests in children with immediate penicillin allergy	5
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	5
The immunologic response to severe acute respiratory syndrome coronavirus 2	5
A 62-year-old man with new-onset bullae	5
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	5
An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial	5
Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis	5
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema	5
The challenge of COVID-19 that permeates the practice of allergy/immunology	5
Criteria positive and criteria negative anaphylaxis, with a focus on undifferentiated somatoform idiopathic anaphylaxis: A review and case series	5
Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood	5
Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape	5
Effects of mechanical washing and drying on the removal of pet allergens	5
Allergen immunotherapy and shared decision-making	5
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure	4
Management and referral patterns for new-onset chronic cough in primary care patients	4
A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness	4
Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment	4
Baker's asthma in bread factory workers	4
Evaluation of nasal symptoms to distinguish eosinophilic from noneosinophilic nasal polyps based on peripheral blood	4
Pediatric sublingual allergen immunotherapy	4
Biologics for oral corticosteroid-dependent asthma	4
Treatment options for moderate to severe atopic dermatitis	4
Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions	4
The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond	4

Persistent urticarial rash in a newborn	4
Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals	4
Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non‐tertiary care private practice setup	4
Are primary care physicians following National Institute of Allergy and Infectious Disease guidelines for the prevention of peanut allergy? A survey-based study	4
Female sex as a risk factor for penicillin drug allergy in the inpatient setting	4
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	4
A brief history of allergen immunotherapy	4
Jellyfish anaphylaxis: A wide spectrum of sensitization routes	4
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities	4
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis	4
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis	4
How satisfactory is on-demand icatibant from the patients' perspective in real life?	4
Standardized allergen extracts for allergen immunotherapy	4
Real-world mapping of allergy immunotherapy in the United States: The argument for improving adherence	4
Current and emerging therapies for eosinophilic esophagitis	4
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	4
Applying personalized medicine to adult severe asthma	4
Future directions in allergen immunotherapy	4
Clinical implications of asthma endotypes and phenotypes	4
A review of allergen immunotherapy in asthma	4
Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study	4
Effect of prenatal phthalate exposure on childhood atopic dermatitis: A systematic review and meta-analysis	4
The effect of the socioeconomic status on the measurement of asthma control	4
Mast cell activation syndrome: Myths and realities	3
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	3
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	3
Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review	3
The role of serum periostin in the diagnosis of asthma: A meta-analysis	3
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment	3
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	3
Validity, reliability, and interpretability of the Brazilian urticaria control test	3
COVID-19, allergic disease and asthma: Extraordinary challenges for the allergist/immunologist	3
A masquerade of recurrent anaphylaxis	3
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	3
Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study	3
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	3
Mast cell disorders and idiopathic anaphylaxis: Evaluation and management	3
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up	3
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	3
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes	3
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist	3
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	3
Psychiatric comorbidity and quality of life in patients with drug hypersensitivity	3
The return of the mixed respiratory bacterial vaccine	3
Assessing cross-reactivity in allergen immunotherapy	3
Salivary microRNAs in pediatric eosinophilic esophagitis	3
A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children	3
What is in your pantry? Entomologic anaphylaxis	3
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	3
Persistent airflow obstruction in inner-city children with asthma	3
Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991‐2018	3
Diagnostic utility of basophil CD203c expression in β-lactam allergy	3
Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns	3
Association of asthma with osteopenia, osteoporosis, osteomalacia, and fractures	3
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	3